All In Biotech

Investigational drug · Phase 3

Pacibekitug

Also called: TOUR006, PAC001

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

2 still active

All registered trials

2

Any phase or sponsor naming "Pacibekitug"

First trial start

2024

Feb 19, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Pacibekitug", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Myocardial Infarction
  • Thyroid Eye Disease
  • Chronic Kidney Diseases
  • Chronic Kidney Insufficiency
  • Chronic Renal Diseases
  • Chronic Renal Insufficiency
  • Kidney Insufficiency, Chronic
  • C-Reactive Protein
  • High Sensitivity C-Reactive Protein
  • Hs-CRP

Approved drugs for the same conditions: Coronary artery disease and heart attack · Chronic kidney disease · Cardiovascular and metabolic · Kidney and urology · Endocrinology and women's health

Largest trials

Live from ClinicalTrials.gov: studies naming "Pacibekitug" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Myocardial Infarction

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.